David M. Nanus

28.7k citations

332 papers · 14.7k indexed · 3 hit papers · h-index 61

Impact in

Pulmonary and Respiratory Medicine top 0.1%
- Prostate Cancer Treatment and Research
- Renal cell carcinoma treatment
- Prostate Cancer Diagnosis and Treatment
Cancer Research top 0.2%
- Cancer Genomics and Diagnostics
- Cancer, Lipids, and Metabolism

Papers in

Pulmonary and Respiratory Medicine 230
- Prostate Cancer Treatment and Research 175
- Renal cell carcinoma treatment 48
Cancer Research 83
- Cancer Genomics and Diagnostics 40
- Cancer, Hypoxia, and Metabolism 22

Co-authors: Neil H. Bander Robert J. Motzer Scott T. Tagawa Matthew I. Milowsky Stanley J. Goldsmith Shankar Vallabhajosula Anthony P. Albino Himisha Beltran
Journals: Journal of Clinical Oncology (112 papers)Cancer Research (20 papers)The Journal of Urology (18 papers)Clinical Cancer Research (12 papers)Annals of Oncology (11 papers)
Partner nations: United States Italy Israel

In The Last Decade

David M. Nanus

316 papers receiving 14.4k citations

Hit Papers

align trajectories log scale

Clinical features of neuroendocrine prostate cancer 2019 · 232 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2019 European Journal of Cancer
2016 Nature Medicine
1996 New England Journal of Medicine

Peers

Countries citing papers authored by David M. Nanus

Since Specialization

Citations

This map shows the geographic impact of David M. Nanus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Nanus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Nanus more than expected).

Fields of papers citing papers by David M. Nanus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Nanus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Nanus. The network helps show where David M. Nanus may publish in the future.

Co-authors

The 25 scholars most cited alongside David M. Nanus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David M. Nanus Line = papers co-authored together David M. Nanus links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Deletion of the transcription factor ATF4 in a model of clear cell renal cell carcinoma Neoplasia ·Yuling Chi, Shireen Chikara, Eduardo Mere Del Aguila, Tuo Zhang, Jacob B. Geri, David M. Nanus, Lorraine J. Gudas	2025	0
2	The Impact of Circulating Tumor Cell HOXB13 RNA Detection in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide Clinical Cancer Research ·Susan Halabi, Siyuan Guo, Joseph J. Park, David M. Nanus, Daniel J. George, Emmanuel S. Antonarakis, Daniel C. Danila, Russell Z. Szmulewitz, Donald P. McDonnell, John D. Norris, Changxue Lu, Jun Luo, Andrew J. Armstrong	2024	8
3	Prognostic value of neutrophil‐to‐lymphocyte ratio in patients with metastatic castration‐resistant prostate cancer receiving prostate‐specific membrane antigen targeted radionuclide therapy The Prostate ·Judith Stangl‐Kremser, Michael Sun, Benedict Ho, Joseph Thomas, Jones T. Nauseef, Joseph R. Osborne, Ana M. Molina, Cora N. Sternberg, David M. Nanus, Neil H. Bander, Scott T. Tagawa	2023	8
4	The genomic landscape of metastatic clear cell renal cell carcinoma after systemic therapy Molecular Oncology ·Johannes C. van der Mijn, Kenneth Eng, Pooja Chandra, Evan Fernandez, Sinan Ramazanoglu, Alexandros Sigaras, Clara Oromendia, Lorraine J. Gudas, Scott T. Tagawa, David M. Nanus, Bishoy F. Faltas, Himisha Beltran, Cora N. Sternberg, Olivier Elemento, Andrea Sboner, Juan Miguel Mosquera, Ana M. Molina	2022	7
5	Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancer Nature Communications ·Nicholas J. Brady, Alyssa Bagadion, Richa Singh, Vincenza Conteduca, Lucie Van Emmenis, Elisa Arceci, Hubert Pakula, Ryan Carelli, Francesca Khani, Martin Bakht, Michael Sigouros, Rohan Bareja, Andrea Sboner, Olivier Elemento, Scott T. Tagawa, David M. Nanus, Massimo Loda, Himisha Beltran, Brian D. Robinson, David S. Rickman	2021	50
6	Androgen receptor variant shows heterogeneous expression in prostate cancer according to differentiation stage Communications Biology ·Ada Gjyrezi, Giuseppe Galletti, Jiaren Zhang, Daniel Worroll, Michael Sigouros, Seaho Kim, Victoria Cooley, Karla V. Ballman, Allyson J. Ocean, Manish A. Shah, Joseph M. Scandura, Andrea Sboner, David M. Nanus, Himisha Beltran, Scott T. Tagawa, Paraskevi Giannakakou	2021	5
7	Circulating Tumor Cell Genomic Evolution and Hormone Therapy Outcomes in Men with Metastatic Castration-Resistant Prostate Cancer Molecular Cancer Research ·Santosh Gupta, Susan Halabi, Gabor Kemeny, Monika Anand, Paraskevi Giannakakou, David M. Nanus, Daniel J. George, Simon G. Gregory, Andrew J. Armstrong	2021	19
8	A Phase Ib/IIa Study of the Pan-BET Inhibitor ZEN-3694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer Clinical Cancer Research ·Rahul Aggarwal, Michael T. Schweizer, David M. Nanus, Allan J. Pantuck, Elisabeth I. Heath, Eric Campeau, Sarah Attwell, Karen Norek, Margo Snyder, Lisa Bauman, Sanjay Lakhotia, Felix Y. Feng, Eric J. Small, Wassim Abida, Joshi J. Alumkal	2020	97
9	Androgen receptor nuclear localization correlates with AR-V7 mRNA expression in circulating tumor cells (CTCs) from metastatic castration resistance prostate cancer patients Physical Biology ·Daniel Worroll, Giuseppe Galletti, Ada Gjyrezi, David M. Nanus, Scott T. Tagawa, Paraskevi Giannakakou	2019	13
10	Oncogenic Addiction to ERBB2 Signaling Predicts Response to Trastuzumab in Urothelial Cancer Journal of the National Comprehensive Cancer Network ·Michael Karass, Rohan Bareja, Ethan Shelkey, Panagiotis J. Vlachostergios, Brian D. Robinson, Francesca Khani, Juan Miguel Mosquera, Douglas S. Scherr, Andrea Sboner, Scott T. Tagawa, Ana M. Molina, Olivier Elemento, David M. Nanus, Bishoy M. Faltas	2019	6
11	Clinical features of neuroendocrine prostate cancer European Journal of Cancer ·Vincenza Conteduca, Clara Oromendia, Kenneth Eng, Rohan Bareja, Michael Sigouros, Ana M. Molina, Bishoy M. Faltas, Andrea Sboner, Juan Miguel Mosquera, Olivier Elemento, David M. Nanus, Scott T. Tagawa, Karla V. Ballman, Himisha Beltran Hit paper breakdown →	2019	232
12	Expression of AR-V7 and ARv567es in Circulating Tumor Cells Correlates with Outcomes to Taxane Therapy in Men with Metastatic Prostate Cancer Treated in TAXYNERGY Clinical Cancer Research ·Scott T. Tagawa, Emmanuel S. Antonarakis, Ada Gjyrezi, Giuseppe Galletti, Seaho Kim, Daniel Worroll, John A. Stewart, Atef Zaher, Ted P. Szatrowski, Karla V. Ballman, Katsuhiro Kita, Shinsuke Tasaki, Yang Bai, Luigi Portella, Brian J. Kirby, Fred Saad, Mario A. Eisenberger, David M. Nanus, Paraskevi Giannakakou	2018	86
13	Role of NADH Dehydrogenase (Ubiquinone) 1 Alpha Subcomplex 4-Like 2 in Clear Cell Renal Cell Carcinoma Clinical Cancer Research ·Denise R. Minton, Leiping Fu, Nigel P. Mongan, Maria M. Shevchuk, David M. Nanus, Lorraine J. Gudas	2016	46
14	Genome-Wide Profiling of TRACK Kidneys Shows Similarity to the Human ccRCC Transcriptome Molecular Cancer Research ·Leiping Fu, Denise R. Minton, Tuo Zhang, David M. Nanus, Lorraine J. Gudas	2015	19
15	The Initial Detection and Partial Characterization of Circulating Tumor Cells in Neuroendocrine Prostate Cancer Clinical Cancer Research ·Himisha Beltran, Adam Jendrisak, Mark Landers, Juan Miguel Mosquera, Myriam Kossaï, Jessica Louw, Rachel Krupa, Ryon P. Graf, Nicole A. Schreiber, David M. Nanus, Scott T. Tagawa, Dena Marrinucci, Ryan Dittamore, Howard I. Scher	2015	108
16	Androgen Receptor Splice Variants Determine Taxane Sensitivity in Prostate Cancer Cancer Research ·Maria Thadani‐Mulero, Luigi Portella, Shihua Sun, Matthew Sung, Alexandre Matov, Robert L. Vessella, Eva Corey, David M. Nanus, Stephen R. Plymate, Paraskevi Giannakakou	2014	191
17	Phase II Study of Lutetium-177–Labeled Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 for Metastatic Castration-Resistant Prostate Cancer Clinical Cancer Research ·Scott T. Tagawa, Matthew I. Milowsky, Michael J. Morris, Shankar Vallabhajosula, Paul J. Christos, Naveed Akhtar, Joseph R. Osborne, Stanley J. Goldsmith, Steven M. Larson, Neeta Pandit Taskar, Howard I. Scher, Neil H. Bander, David M. Nanus	2013	308
18	Activation of HIF2α in Kidney Proximal Tubule Cells Causes Abnormal Glycogen Deposition but not Tumorigenesis Cancer Research ·Leiping Fu, Gang Wang, Maria M. Shevchuk, David M. Nanus, Lorraine J. Gudas	2013	34
19	Correction: Functional Characterization of Circulating Tumor Cells with a Prostate-Cancer-Specific Microfluidic Device PLoS ONE ·Brian J. Kirby, Mona Jodari, Matthew S. Loftus, Gunjan Gakhar, Erica D. Pratt, Chantal Chanel‐Vos, Jason P. Gleghorn, Steven M. Santana, He Liu, James P. Smith, Vicente N. Navarro, Scott T. Tagawa, Neil H. Bander, David M. Nanus, Paraskevi Giannakakou	2012	36
20	Taxane-Induced Blockade to Nuclear Accumulation of the Androgen Receptor Predicts Clinical Responses in Metastatic Prostate Cancer Cancer Research ·Medha S. Darshan, Matthew S. Loftus, Maria Thadani‐Mulero, Benjamin Levy, Daniel Escuín, Xi Kathy Zhou, Ada Gjyrezi, Chantal Chanel‐Vos, Ruoqian Shen, Scott T. Tagawa, Neil H. Bander, David M. Nanus, Paraskevi Giannakakou	2011	343

About David M. Nanus

David M. Nanus is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology, having authored 332 papers that have together received 14.7k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (175 papers), Radiopharmaceutical Chemistry and Applications (107 papers), Renal cell carcinoma treatment (48 papers), Cancer Genomics and Diagnostics (40 papers), Peptidase Inhibition and Analysis (39 papers), Bladder and Urothelial Cancer Treatments (32 papers), Cancer Immunotherapy and Biomarkers (28 papers) and Cancer, Hypoxia, and Metabolism (22 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (8.2k citations), Cancer Research (3.5k citations), Oncology (5.0k citations), Radiology, Nuclear Medicine and Imaging (2.5k citations) and Molecular Biology (6.2k citations). David M. Nanus has collaborated with scholars based in United States, Italy and Israel. Frequent co-authors include Neil H. Bander, Robert J. Motzer, Scott T. Tagawa, Matthew I. Milowsky, Stanley J. Goldsmith, Shankar Vallabhajosula, Anthony P. Albino, Himisha Beltran, Lale Kostakoğlu and Paraskevi Giannakakou. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, The Journal of Urology, Clinical Cancer Research and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact